LQDA
Liquidia Corp
NASDAQ · Healthcare · Biotechnology · US
$47.38
+12.27%Forward multiples
Based on analyst estimates
- P/E forward
- 51.41x
- P/E 2026E
- 23.77x
- P/E 2027E
- 22.04x
- P/E 2028E
- 14.58x
- P/S forward
- 5.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.20x
- PEG TTM
- —
- Price / book
- 21.74x
- Price / sales
- 9.41x
- Price / cash flow
- 53.66x
Enterprise value
- Enterprise value
- $4.1B
- EV / sales
- 9.06x
- EV / EBITDA
- 22.98x
- EV / EBIT
- 24.24x
- Market cap
- $4.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026